Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs PACCAR Inc. Common Stock (PCAR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs PACCAR Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while PACCAR Inc. Common Stock trades at $108.04 (market cap $57.72B). The key difference: PACCAR Inc. Common Stock is far larger — about 4.6× Halozyme Therapeutics Inc. Common Stock's market cap, and PACCAR Inc. Common Stock pays a 1.28% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and PACCAR Inc. Common Stock for 1 Days on average.
| HALO | PCAR | |
|---|---|---|
Market Cap | $12.58B | $57.72B |
Volume | 2,179,278 | 3,769,505 |
Sector | Health | Industrials |
52-Week High | $115.22 | $138.21 |
52-Week Low | $61.63 | $93.00 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $63.58B |
Dividend Yield | — | 1.28% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About PACCAR Inc. Common Stock
PACCAR designs and manufactures heavy-duty trucks under brands including Peterbilt, Kenworth, and DAF. It also provides parts, financial services, and technology for commercial vehicles.
Read more on PCAR →
